SmartStop Self Storage and AXCS Capital Form Strategic Joint Venture to Provide Bridge Debt and Preferred Equity Capital Across the Self-Storage Sector Mar 24, 2026 7:05 PM Eastern Daylight Time SmartStop Self Storage and AXCS Capital Form Strategic Joint Venture to Provide Bridge Debt and Preferred Equity Capital Across the Self-Storage Sector Share LADERA RANCH, Calif.--(BUSINESS WIRE)--SmartStop Self Storage REIT, Inc. ("SmartStop†) (NYSE: SMA), an internally managed real estate investment trust and a ...

Completes Initial Sale of 17% of its China Business JV to UTG Playboy Makes Initial $15 Million Debt Pay Down with Transaction Proceeds Transaction Advances Asset-Light Strategy and Accelerates Debt Reduction LOS ANGELES, March 23, 2026 (GLOBE NEWSWIRE) -- Playboy, Inc. (NASDAQ: PLBY) (the “Company” or “Playboy”), a global pleasure and leisure company, today announced the initial closing of its previously announced transaction to ultimately sell 50% of its China business to UTG Brands Management Group (“UT ...

FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon†), an affiliate of Monroe Capital, announced today the formation of a new joint venture with CR Financial Holdings, Inc. ("CRFH†), the holding company for Roth Capital Partners, LLC ("Roth†). The joint venture will provide growth capital financing solutions to small- and micro-cap public companies based primarily in the U.S. Horizon and CRFH will make initial capital commitments totaling $100 mil. ...

Core Viewpoint - Pony.ai and Chenqi Mobility have launched a joint Robotaxi fleet with the delivery of over 100 Gen-7 vehicles, marking a significant step in the commercialization of autonomous driving technology in China [1][2]. Group 1: Partnership and Collaboration - Pony.ai and Chenqi Mobility have signed an upgraded strategic cooperation agreement to jointly build a Robotaxi fleet and expand geographic coverage [2][3]. - The partnership aims to combine Pony.ai's technological leadership with Chenqi's expertise in mobility platforms, creating a scalable commercialization model for fleet operations [3][7]. Group 2: Technology and Vehicle Features - The Gen-7 Robotaxi platform is noted for its advanced autonomous driving solutions, with a 70% reduction in the cost of the autonomous driving kit compared to the previous generation [4]. - The vehicle is designed for a lifespan of up to 600,000 kilometers and includes passenger-focused enhancements such as Bluetooth unlocking, in-vehicle voice interaction, and improved ride comfort features [4][5]. Group 3: Commercial Viability and Market Expansion - Pony.ai has achieved positive unit economics with Gen-7 Robotaxis in major cities like Guangzhou and Shenzhen, indicating strong commercial viability [6]. - The company is on track to exceed its target of 3,000 Robotaxi vehicles by the end of 2026, driven by increasing collaborations with fleet and mobility partners [8].

Century Communities Will Debut New Homes in Northwest Houston at Joint Grand Opening Accessibility StatementSkip Navigation Top national homebuilder reveals new community in high-demand Hockley, TX HOCKLEY, Texas, March 18, 2026 /PRNewswire/ -- Century Communities, Inc. (NYSE: CCS)—a top national homebuilder, industry leader in online home sales, and featured on America's Most Trustworthy Companies and World's Most Trustworthy Companies by Newsweek—is thrilled to announce the Grand Opening of Maple Woods, a ...

Core Viewpoint - Capital Southwest Corporation and Trinity Capital Inc. have formed a joint venture to invest primarily in first-out senior secured debt opportunities in the lower middle market [1][2]. Group 1: Joint Venture Structure - The joint venture will be equally owned by both companies, with each committing $50 million and holding a 50% equity interest [2]. - Investment and operational decisions will be managed by a board of managers with equal representation from both partners [2]. Group 2: Strategic Benefits - The joint venture is expected to enhance Capital Southwest's ability to compete for high-quality lower middle market opportunities by providing more flexible capital solutions [3]. - Trinity Capital aims to diversify its portfolio into the lower middle market and expand its managed funds business through this partnership [3]. Group 3: Company Profiles - Capital Southwest Corporation, based in Dallas, Texas, has approximately $2.0 billion in investments at fair value as of December 31, 2025, focusing on middle market businesses with investments ranging from $5 million to $50 million [4]. - Trinity Capital Inc., headquartered in Phoenix, Arizona, is an international alternative asset manager that focuses on private credit markets across five distinct lending verticals [5].

Core Insights - The company is focused on the development of transcript-related projects, indicating a commitment to enhancing its offerings in this area [1] Group 1 - The company publishes thousands of quarterly earnings calls each quarter, showcasing its extensive coverage and growth in the transcript market [1] - There is an ongoing effort to expand coverage, suggesting a strategic initiative to capture more market share and improve service offerings [1]

Financial Performance - The company delivered over 14.4 million patient visits in 2025, generating system-wide sales of approximately $532.4 million, compared to $530.3 million in 2024[21]. - The company has increased annual system-wide sales from $22.3 million in 2012 to $532.4 million in 2025, while expanding the number of clinics from 33 to 960[45]. - System-wide same-store sales for 2025 increased by $2.1 million, remaining flat on a percentage basis, reflecting the resilience of the business model[57]. - The company experienced flat comparable sales for the full year 2025, indicating potential challenges in maintaining growth[112]. - The company experienced net losses in both 2023 and 2024, despite achieving profitability from 2018 through 2022 and again in 2025[139]. Clinic Operations and Expansion - As of December 31, 2025, the company operated 960 clinics, with an additional 82 franchise licenses sold but not yet developed, and 57 letters of intent for future clinic licenses[22]. - The company completed 41 clinic divestitures in 2025, marking a significant step towards transitioning to a pure-play franchisor model[26]. - The company has granted franchises for an additional 82 clinics and executed letters of intent for 57 future clinic licenses, indicating ongoing expansion efforts[63]. - The company operates over 960 clinics across 43 states, making it the largest chiropractic franchisor in the U.S., with a brand size approximately six times larger than the next largest chain as of December 2025[47]. - The company refranchised 31 clinics in Arizona and New Mexico for $8.3 million in cash, with an agreement to open an additional 10 clinics in the same region[210]. Patient Engagement and Market Position - The company attracted an average of 827 new patients per clinic in 2025, significantly higher than the industry average of 364 new patients[39]. - According to a patient survey, 36% of new patients in 2024 had never tried chiropractic care before visiting the company, up from 16% in 2013[29]. - The highest-performing clinic in the system saw monthly sales increase from approximately $45 thousand in January 2012 to approximately $165 thousand in December 2025, indicating significant growth potential[46]. - The chiropractic services market in the U.S. is valued at approximately $21.9 billion annually, with a projected 10% growth in chiropractor employment from 2023 to 2033[34]. - There is a growing interest among Americans in seeking effective, affordable natural solutions for general wellness, which presents an opportunity for the company to accelerate the growth of its network[218]. Financial Strategy and Royalties - The company collects a 7.0% royalty on gross sales from franchised clinics and a national marketing fee of 2.0% of gross sales[22]. - The company is focused on increasing royalty income through the acceleration of clinic openings and refranchising remaining company-owned clinics[59]. - The company relies on franchise fees and royalties as it executes its refranchising strategy, which may lead to decreased total revenue as company-owned clinics are sold[138]. - The company plans to generate significant proceeds from refranchising to create capital allocation opportunities, including reinvestment in the brand and potential mergers or acquisitions[215]. Regulatory and Compliance Issues - The regulatory environment is becoming more complex, with new privacy laws requiring additional investment in compliance programs[68]. - The company is subject to various federal regulations, including the Fair Labor Standards Act, which may increase labor costs due to minimum wage increases effective January 1, 2026[84]. - The company believes it is in substantial compliance with applicable laws regarding the corporate practice of chiropractic, despite ongoing scrutiny in several states[80]. - The company has retained legal counsel in response to investigations by state boards regarding its business model, with some investigations being closed without findings of violation[75]. - The company is subject to extensive federal, state, and local laws, including those governing franchisor-franchisee relationships and data privacy, which could lead to significant compliance costs[153]. Cybersecurity and Data Privacy - The company experienced a data breach in November 2022, affecting a limited number of individuals, but it was determined that the breach did not result in the release of sensitive personal information[70]. - The company has a robust privacy compliance program and implemented security training systems to enhance cybersecurity awareness among employees[190]. - The company is committed to continuous monitoring and updating of cybersecurity measures in alignment with ISO 27001 standards[191]. - The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity efforts, meeting quarterly to discuss strategies and incidents[183]. - Compliance with evolving privacy and security laws may result in increased costs and operational constraints[165]. Workforce and Recruitment - The company emphasizes the importance of attracting and retaining a diverse and engaged workforce to support its ongoing success[90]. - The company continues to enhance its recruitment strategies and strengthen relationships with chiropractic colleges to attract qualified candidates[93]. - The nationwide labor shortage has negatively impacted the company's ability to recruit qualified chiropractors, leading to reduced net revenues[108]. - The company is committed to providing market competitive compensation and benefits, including comprehensive medical coverage and retirement savings plans[97]. - As of December 31, 2025, the company employed approximately 202 full-time and 128 part-time employees[91]. Economic and Market Challenges - Inflation has increased labor costs and interest rates, which may reduce discretionary spending and adversely affect the company's business[109]. - Economic conditions, including high inflation expected to persist through at least 2026, could adversely affect consumer discretionary spending and clinic traffic[122]. - The company anticipates that fiscal 2026 will be a volatile macroeconomic environment with elevated levels of cost inflation[110]. - The company anticipates that 2026 will continue to be a volatile macroeconomic environment due to unfavorable global economic or political conditions, including labor shortages and inflation[219]. Legal and Liability Concerns - Malpractice claims have been a concern, with the company maintaining minimum professional liability insurance coverage of $1.0 million per occurrence and $3.0 million in annual aggregate[157]. - The company faces potential liabilities due to evolving federal and state regulations regarding joint employer status, which could impact operational costs and franchisee relationships[146]. - Changes in ethical guidelines and operating standards for chiropractors could adversely affect the company's business operations[156]. - The company may face substantial costs related to intellectual property litigation, which could divert resources and affect financial performance[159].

分组1 - The Joint Corp. reported quarterly earnings of $0.06 per share, exceeding the Zacks Consensus Estimate of $0.05 per share, with an earnings surprise of +33.33% [1] - The company achieved revenues of $15.17 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 10.59% and showing an increase from $14.45 million year-over-year [2] - The Joint has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates four times in the same period [2] 分组2 - The stock has underperformed the market, losing about 2.4% since the beginning of the year compared to a 1% decline in the S&P 500 [3] - The current consensus EPS estimate for the coming quarter is $0.15 on $14 million in revenues, and for the current fiscal year, it is $0.57 on $55.41 million in revenues [7] - The Zacks Industry Rank for Medical - HMOs is currently in the bottom 9% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Financial Data and Key Metrics Changes - Revenue from continuing operations increased by 3.1% in Q4 2025 compared to Q4 2024, while consolidated adjusted EBITDA rose by 7.8% [9][18] - For the full year 2025, revenue was $54.9 million, up from $52.2 million in 2024, and consolidated net income increased to $2.9 million from a loss of $5.8 million in 2024 [21][22] Business Line Data and Key Metrics Changes - System-wide sales decreased by 3.9% to $130 million in Q4 2025, with comp sales down 3.8% [18] - The total clinic count at year-end was 960, down from 967 the previous year, with 29 new clinics opened and 41 refranchised during 2025 [19] Market Data and Key Metrics Changes - The company is focusing on improving new patient acquisition through enhanced marketing strategies, shifting from local to national advertising to increase brand awareness [12][34] - New patient acquisition trends have shown improvement each month since the launch of the new marketing initiatives, although they remain lower than the previous year [14][54] Company Strategy and Development Direction - The company is on track to complete the first phase of its transformation journey, Joint 2.0, by the end of 2025, transitioning to a pure-play franchisor model [5][27] - Future growth strategies include expanding operations into new channels and markets, focusing on integrated treatments and leveraging data from wearable technology [28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving long-term goals despite current challenges, emphasizing the importance of improving marketing effectiveness and patient retention [27][62] - The company anticipates that the second half of 2026 will show improved comp sales due to easier comparisons and traction from current initiatives [51][66] Other Important Information - The company repurchased 1.1 million shares for $9 million in Q4 2025, with a total of 1.3 million shares repurchased for $11.3 million throughout the year [9][22] - The company expects system-wide sales for 2026 to range from $519 million to $552 million, with comp sales projected between -3% to 3% [22] Q&A Session Summary Question: Can you share the attrition and new patient add metrics? - Management noted that new patient flow has been the weakest component of active member growth, but early signs from new marketing efforts are positive [31][32] Question: How are you evolving marketing initiatives for 2026? - The focus remains on shifting investment from local to national marketing, improving creative messaging, and addressing changes in search behaviors due to AI [34][35] Question: How did the three-tiered pricing pilot go? - The $10 pricing increase showed more benefit compared to the $2 increase, and further testing is ongoing before broader rollout [38][39] Question: What specific leading indicators give confidence that comps will improve in 2026? - Management highlighted early signs of improvement in leads and new patients, with expectations for better performance in the second half of the year [51][52] Question: Does your guidance include a pricing increase? - No, the guidance does not include any pricing increase as the results from recent tests were still uncertain [67]